India Point of Care Diagnostics Market to Grow with a CAGR of 8.45% through 2030
Increased health
awareness is expected to drive the India Point of Care Diagnostics Market
growth in the forecast period, 2026-2030.
According to
TechSci Research report, “India Point of Care Diagnostics Market - By Region
and Competition, Forecast & Opportunities, 2030F”, the India Point of
Care Diagnostics Market stood at USD 628.32 Million in 2024 and is anticipated
to grow with a CAGR of 8.45% through 2030. Government initiatives and investments play a crucial role
in driving the growth of the Point of Care (POC) diagnostics market,
particularly in emerging economies like India. In recent years, the Indian
government has taken significant steps to enhance healthcare accessibility,
improve diagnostic infrastructure, and support innovation in medical
technologies.
One
of the key initiatives is the National Health Mission (NHM), which focuses on
improving healthcare access in rural and underserved regions, where POC
diagnostics can play a vital role in providing quick and accurate results
without the need for sophisticated laboratory setups. The Pradhan Mantri Jan
Arogya Yojana (PMJAY), also known as Ayushman Bharat, is another significant
initiative that aims to provide affordable healthcare to millions of Indians.
Under this scheme, there is a growing emphasis on increasing the adoption of
innovative diagnostic tools, including POC devices, to make healthcare services
more accessible and efficient.
Increased
health awareness is a significant driver for the growth of the Point of Care
(POC) diagnostics market, as it is directly influencing both consumer behavior
and healthcare practices. Over the past few years, there has been a noticeable
shift in how people view healthcare and wellness, especially with the rise of
chronic diseases, lifestyle-related conditions, and the ongoing global health
challenges like the COVID-19 pandemic. This heightened awareness has led to a
growing demand for early detection, regular monitoring, and preventive
healthcare, all of which are addressed effectively through POC diagnostics.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "India Point of Care Diagnostics Market”
The India Point
of Care Diagnostics Market is segmented into product, end use, regional
distribution, and company.
Based
on Product, Glucose Testing emerged as the dominating segment in the India
Point of Care Diagnostics Market in 2024. This is largely due to the high
prevalence of diabetes, which is a significant health concern in India. The
growing number of diabetic patients and the need for regular monitoring of
blood glucose levels drive the demand for glucose testing devices. These tests
are essential for both diabetic patients and healthcare providers to track and
manage the condition effectively.
Based on Region,
North India emerged as the fastest growing region in the India Point of
Care Diagnostics Market in 2024. This
growth can be attributed to several factors, including the rapid urbanization
in cities like Delhi, Chandigarh, and Lucknow, a growing healthcare
infrastructure, and increased health awareness among the population.
Additionally, the increasing prevalence of chronic diseases such as diabetes
and cardiovascular conditions has led to a higher demand for diagnostic
services in the region. North India is also witnessing a surge in the adoption
of modern diagnostic technologies in both urban and rural areas, as healthcare
providers look to offer more accessible and efficient solutions.
Major companies
operating in India Point of Care Diagnostics Market are:
- Roche
Products (India) Pvt. Ltd.
- Qiagen
India Pvt Ltd.
- Danaher
Corporation
- Becton
Dickinson Private Limited
- BioMérieux
- Siemens
Healthcare Private Limited
- Abbott
India Ltd
- Trividia
Health, Inc.
- Spectra
Medical India Pvt Ltd
- AccuBioTech
Co., Ltd.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“Improving healthcare access in rural
areas is playing a pivotal role in expanding the Point of Care (POC)
diagnostics market, especially in countries like India. Rural areas have
traditionally struggled with limited access to quality healthcare, hindered by
a lack of infrastructure, medical personnel, and proximity to healthcare
facilities. However, recent initiatives aimed at improving healthcare access
are creating opportunities for POC diagnostics. The integration of telemedicine
and mobile health solutions has also played a significant role, especially
during the COVID-19 pandemic.”, said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“India Point of Care
Diagnostics Market By Product (Glucose Testing, Hb1Ac Testing, Coagulation
Testing, Fertility/Pregnancy, Infectious Disease, Cardiac Markers, Thyroid
Stimulating Hormone, Hematology, Primary Care Systems, Others), By End Use
(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory),
By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth
potential of India Point of Care Diagnostics Market and provides statistics
& information on market size, structure, and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in India Point of Care Diagnostics Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com